Activity of pivaloyloxymethyl butyrate, a novel anticancer agent, on primary human tumor colony-forming units

Investigational New Drugs

Volumn 16, Issue 2, 1998, Pages 113-119

  Siu, Lillian L ^a   Von Hoff, Daniel D ^a   Rephaeli, Ada ^b   Izbicka, Elzbieta ^a   Cerna, Cesario ^a   Gomez, Lionel ^a   Rowinsky, Eric K ^a   Eckhardt, S Gail ^a  

^a University of Texas Health Science Center at San Antonio   (United States)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Butyrate analogs; Differentiation; Investigational agents

Indexed keywords

ANTINEOPLASTIC AGENT; NEW DRUG; PIVALOYLOXYMETHYL BUTYRATE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; COLONY FORMATION; COLORECTAL CANCER; CONTROLLED STUDY; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MELANOMA; OVARY CANCER; PRIORITY JOURNAL; TUMOR CELL;

ANTINEOPLASTIC AGENTS; BUTYRATES; CLONING, MOLECULAR; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, NEOPLASM; DRUGS, INVESTIGATIONAL; HUMANS; TIME FACTORS; TUMOR CELLS, CULTURED; TUMOR STEM CELLS;

EID: 0031730897     PISSN: 01676997     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006049227744     Document Type: Article

References (16)

1. Rephaeli A, Rabizadeh E, Aviram A, Shaklai M, Ruse M, Nudelman A: Derivatives of butyric acid as potential antineoplastic agents. Int J Cancer 49: 66-72, 1991
2. Rabizadeh E, Shaklai M, Nudelman A, Eisenbach L, Rephaeli A: Rapid alteration of c-myc and c-jun expression in leukemic cells induced to differentiate by a butyric acid prodrug. FEBS Lett 328: 225-229, 1993
3. Zimra Y, Wasserman L, Maron L, Shaklai M, Nudelman A, Rephaeli A: Butyric acid and pivaloyloxymethyl butyrate, AN-9, a novel butyric acid derivative, induce apoptosis in HL-60 cells. J Cancer Res Clin Oncol 123: 152-160, 1997
4. Aviram A, Zimrah Y, Shaklai M, Nudelman A, Rephaeli A: Comparison between the effect of butyric acid and its prodrug pivaloyloxymethyl butyrate on histones hyperacetylation in an HL-60 leukemic cell line. Int J Cancer 56: 906-909, 1994
5. Nudelman A, Ruse M, Aviram A, Rabizadeh E, Shaklai M, Zimrah Y, Rephaeli A: Novel anticancer prodrugs of butyric acid. J Med Chem 35: 687-694, 1992
6. Hamburger AW, Salmon SE: Primary bioassay of human tumor stem cells. Science 197: 461-463, 1977
7. Salmon SE, Hamburger AW, Soehnlen B, Durie BG, Alberts DS, Moon TE: Quantitation of differential sensitivity of human tumor stem cells to anticancer drugs. N Engl J Med 298: 1321-1327, 1978.
8. Von Hoff DD: He's not going to talk about in vitro predictive assays again, is he? J Natl Cancer Inst 82: 96-101, 1990
9. Von Hoff DD, Clark GM, Stogdill BJ, Sarosdy MF, O'Brien MT, Casper JT, Mattox DE, Page CP, Cruz AB, Sandbach JF: Prospective clinical trial of a human tumor cloning system. Cancer Res 43: 1926-1931, 1983
10. Shoemaker RH, Wolpert-Defillipes MK, Kern DH, Lieber MM, Makuch RW, Melnick NR, Miller WT, Salmon SE, Simon RM, Venditti JM, Von Hoff DD: Application of a human tumor colony-forming assay to new drug screening. Cancer Res 45: 2145-2153, 1985
11. Hanauske U, Hanauske AR, Marshall MH, Muggia VA, Von Hoff DD: Biphasic effects of vanadium salts on in vitro tumor colony growth. Int J Cell Cloning 5: 170-178, 1987
12. Rowinsky EK, Donehower RC: Drug therapy: Paclitaxel (Taxol). N Engl J Med 332: 1004-1114, 1995
13. Koeffler HP: Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications. Blood 62: 709-721, 1983
14. Novogrodsky A, Dvir A, Ravid A, Shkolinik T, Stenzel KH, Rubin AL, Zaizov R: Effect of polar organic compounds on leukemic cells: butyrate-induced reduced partial remission of acute myelogenous leukemia in a child. Cancer 51: 9-14, 1983
15. Miller AA, Kurschel E, Osieka R, Schmidt C: Clinical pharmacology of sodium butyrate in patients with acute leukemia. Eur J Cancer Clin Oncol 23: 1283-1287, 1987
16. Aviram A, Rephaeli A, Shaklai M, Nudelman A, Ben-Dror I, Maron L, Rabizadeh E: Effect of the cytostatic butyric acid pro-drug, pivaloyloxymethyl butyrate, on the tumorigenicity of cancer cells. J Cancer Res Clin Oncol 123: 267-271, 1997